CorMedix Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio

The stock price for CorMedix Inc (CRMD) currently stands at $3.78. The stock experienced a substantial increase in the last session, hitting $4.05 after starting at $4.05. The stock’s lowest price was $3.73 before closing at $4.01.

CorMedix Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $6.09 on 06/22/23, while the lowest value for the same period was recorded at $2.57 on 11/15/23.

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.


52-week price history of CRMD Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. CorMedix Inc’s current trading price is -37.93% away from its 52-week high, while its distance from the 52-week low is 47.08%. The stock’s price range during the 52-week period has remained between $2.57 and $6.09. In the Healthcare sector, the company’s shares saw a trading volume of around 1.53 million for the day, which was evidently higher than the average daily volume of 0.78 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

CorMedix Inc (CRMD) has experienced a quarterly decline of -8.70% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 207.18M and boasts a workforce of 41 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 3.76, with a change in price of -0.16. Similarly, CorMedix Inc recorded 753,408 in trading volume during the last 100 days, posting a change of -4.06%.

Examining CRMD’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for CRMD stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.

CRMD Stock Stochastic Average

As of today, CorMedix Inc’s raw stochastic average for the last 50 days stands at 68.36%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 68.36%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 73.07% and 61.48%, respectively.

CRMD Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price decrease of -10.43%. However, over the past six months, we’ve seen a stronger performance of -26.32%. The price of CRMD fallen by 19.62% over the last 30 days. And in the last five days, it has surged by 21.54%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts